Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRORAND - Prostate Risk or Radiology Assessment Non-inferiority Design, a Comparison of Upfront MRI vs Risk Calculator in Men With Suspected Prostate Cancer

NCT07422597 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.

NCT NCT07422597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07422597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRORAND - Prostate Risk or Radiology Assessment Non-inferiority Design, a Comparison of Upfront MRI vs Risk Calculator in Men With Suspected Prostate Cancer
Lead sponsor
Norwegian University of Science and Technology
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2026
Completion date
December 31, 2029
Enrollment
1,016 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer